BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14719381)

  • 1. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury.
    Song WC
    Curr Dir Autoimmun; 2004; 7():181-99. PubMed ID: 14719381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
    Gorter A; Meri S
    Immunol Today; 1999 Dec; 20(12):576-82. PubMed ID: 10562709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitro.
    Christiansen D; Milland J; Thorley BR; McKenzie IF; Loveland BE
    Eur J Immunol; 1996 Mar; 26(3):578-85. PubMed ID: 8605924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Self- and non-self recognition mechanism via the complement system].
    Okada N
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():279-83. PubMed ID: 15861669
    [No Abstract]   [Full Text] [Related]  

  • 5. Membrane-associated proteins regulating the complement system: functions and deficiencies.
    Schieren G; Hänsch GM
    Int Rev Immunol; 1993; 10(1):87-101. PubMed ID: 7688019
    [No Abstract]   [Full Text] [Related]  

  • 6. The regulation of the complement system: insights from genetically-engineered mice.
    Turnberg D; Botto M
    Mol Immunol; 2003 Sep; 40(2-4):145-53. PubMed ID: 12914820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
    Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
    Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
    [No Abstract]   [Full Text] [Related]  

  • 8. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
    Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
    Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
    Miwa T; Song WC
    Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.
    van Beek J; van Meurs M; 't Hart BA; Brok HP; Neal JW; Chatagner A; Harris CL; Omidvar N; Morgan BP; Laman JD; Gasque P
    J Immunol; 2005 Feb; 174(4):2353-65. PubMed ID: 15699172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complement regulatory proteins].
    Miyagawa S
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():274-8. PubMed ID: 15861668
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
    Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
    Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement regulatory proteins on human and porcine nontransgenic and hDAF transgenic islet cells: expression and role in susceptibility to lysis by human serum.
    Bennet W; Sundberg B; Elgue G; Brendel M; Richards A; White DJ; Groth C; Korsgren O
    Transplant Proc; 2000 Aug; 32(5):1066. PubMed ID: 10936358
    [No Abstract]   [Full Text] [Related]  

  • 14. The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy.
    Geller A; Yan J
    Front Immunol; 2019; 10():1074. PubMed ID: 31164885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement regulatory proteins and autoimmunity.
    Kawano M
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):367-72. PubMed ID: 11140463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound complement regulatory proteins as biomarkers and potential therapeutic targets for SLE.
    Das N; Biswas B; Khera R
    Adv Exp Med Biol; 2013; 735():55-81. PubMed ID: 23402019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
    Hourcade D; Liszewski MK; Krych-Goldberg M; Atkinson JP
    Immunopharmacology; 2000 Aug; 49(1-2):103-16. PubMed ID: 10904110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
    Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement regulatory proteins in glomerular diseases.
    Nangaku M
    Kidney Int; 1998 Nov; 54(5):1419-28. PubMed ID: 9844117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG; Mold C; Atkinson JP; Medof ME
    J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.